Literature DB >> 33961886

Rational Combination Therapy to Overcome the Plateau of Drug Efficacy in Inflammatory Bowel Disease.

Carlos Stalgis1, Parakkal Deepak2, Saurabh Mehandru3, Jean-Frederic Colombel3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33961886     DOI: 10.1053/j.gastro.2021.04.068

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  4 in total

Review 1.  Update on Immune Checkpoint Inhibitor Enterocolitis.

Authors:  Molly R Kelly-Goss; Yousef R Badran; Michael Dougan
Journal:  Curr Gastroenterol Rep       Date:  2022-10-20

2.  Inflammatory Bowel Disease Therapy: Beyond the Immunome.

Authors:  Claudio Fiocchi; Dimitrios Iliopoulos
Journal:  Front Immunol       Date:  2022-05-09       Impact factor: 8.786

Review 3.  Biomarker discovery for personalized therapy selection in inflammatory bowel diseases: Challenges and promises.

Authors:  Dahham Alsoud; Séverine Vermeire; Bram Verstockt
Journal:  Curr Res Pharmacol Drug Discov       Date:  2022-01-26

4.  Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.

Authors:  Laurent Goessens; Jean-Frédéric Colombel; An Outtier; Marc Ferrante; Joao Sabino; Ciaran Judge; Reza Saeidi; Louise Rabbitt; Alessandro Armuzzi; Eugeni Domenech; George Michalopoulos; Anneline Cremer; Francisco Javier García-Alonso; Tamas Molnar; Konstantinos Karmiris; Krisztina Gecse; Joep Van Oostrom; Mark Löwenberg; Klaudia Farkas; Raja Atreya; Davide Giuseppe Ribaldone; Christian Selinger; Frank Hoentjen; Benoit Bihin; Shaji Sebastian; Jean-François Rahier
Journal:  United European Gastroenterol J       Date:  2021-10-25       Impact factor: 4.623

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.